The partnership focuses on the development and commercialization of specialized medical aesthetic tools, including skin boosters, cosmeceuticals, and advanced medical devices. By leveraging HIGHER Corporation’s global network of physicians and its flagship HILO WAVE® platform, the companies intend to create a seamless ecosystem where clinical aftercare products are distributed directly through professional medical channels.

Sangmok Lee, CEO of Amorepacific Holdings, emphasized the goal of merging skin science with medical technology to deliver novel consumer experiences. In Yong Kim, CEO of HIGHER Corporation, noted that the move reinforces the company’s commitment to science-driven innovation, specifically utilizing the proprietary DHC® technology found in its HILO WAVE® range. This joint effort marks a shift for Amorepacific as it seeks to expand its footprint beyond traditional cosmetics into the high-growth sector of medical-grade skin remodeling.